Within the year, 7 ETFs have been born with performances "doubling basis".

With the net value updated on July 29th, several ETFs have achieved "doubled performance" within the year. According to Wind data, as of now, 7 non-cargo ETFs have doubled their net value returns within the year. The Haitong Bocom Schroder Hang Seng Innovative Drug ETF leads the market with a 107.67% net value return within the year; following closely behind is the Wanxiang CSI Hang Seng Innovative Drug ETF, with a net value return of 106.87% within the year; ranking third is the GF CSI Hong Kong Innovative Drug ETF, with a net value return of 106.39% within the year. In addition, the Huatai Bairui Hang Seng Innovative Drug ETF, Yinhuaguo CSI Hang Seng Innovative Drug ETF, Invesco Great Wall CSI Hang Seng Innovative Drug ETF, and Fuguo Hang Seng Healthcare ETF have also doubled their net value within the year, with net value returns of 106.36%, 105.67%, 103.36%, and 101.21% respectively.